Gaudium IVF IPO GMP Remains Steady On Day 2 Of Subscription

The initial public offering (IPO) of Gaudium IVF and Women Health Ltd., a Delhi-based In Vitro Fertilisation (IVF) treatment provider, experienced a muted reception from investors on its first day of bidding, February 20. The offering was subscribed 0.88 times overall.

IPO Performance and Market Response

Gaudium IVF and Women Health aims to raise Rs 165 crore through its IPO. By Monday, the IPO had reached a subscription level of 1.37 times. The grey market currently indicates a premium of nearly 11% over the IPO price.

Did You Know? Gaudium IVF and Women Health Ltd. Was incorporated in 2015 and currently operates across thirty locations in India.

Grey Market Premium (GMP)

As of February 23, the grey market premium for the Gaudium IVF IPO stood at Rs 8.5 per share. This suggests a potential listing price of Rs 87.5, a premium of 10.76% over the IPO price of Rs 79 per share. The GMP is based on speculation and does not represent official data.

Subscription Details

On the first day of bidding, the IPO received bids for 1,28,56,347 shares against an offer of 1,46,20,340 shares. Retail investors drove the subscription, booking their quota 1.37 times. Non-Institutional Investors (NIIs) subscribed 0.91 times, while Qualified Institutional Buyers (QIBs) did not submit any applications on the first day.

IPO Structure and Investment Details

The Gaudium IVF IPO includes a fresh issue of 1.14 crore shares, amounting to Rs 90 crore and an offer-for-sale (OFS) of 95 lakh shares, worth Rs 75 crore. The price band for the IPO has been set between Rs 75 and Rs 79 per share.

Retail investors can apply for a minimum of 189 shares, requiring an investment of at least Rs 14,931. Small NIIs need to apply for at least 14 lots (Rs 2,09,034), while larger NIIs require a minimum of 67 lots (Rs 10,00,377).

Expert Insight: The initial lukewarm response, followed by increased subscription, suggests a degree of investor caution coupled with potential interest driven by the grey market premium. This dynamic highlights the complexities of IPO investment and the influence of short-term market sentiment.

Key Dates and Listing

The subscription window for the Gaudium IVF IPO closes on February 24. Share allotment is expected to be finalized on February 25, with refunds processed on the same day. The shares are tentatively scheduled to be listed on the NSE and BSE on February 27.

Use of IPO Funds

Gaudium IVF and Women Health intends to use the funds raised through the IPO for establishing new IVF centres, repaying debts, and for general corporate purposes.

Frequently Asked Questions

What is the price band for the Gaudium IVF IPO?

The price band for the Gaudium IVF IPO has been fixed at Rs 75 to Rs 79 per share.

When does the subscription window for the IPO close?

The subscription window for the Gaudium IVF IPO will remain open until February 24.

What is the grey market premium (GMP) for the IPO?

As of February 23, the grey market premium for the Gaudium IVF IPO stood at Rs 8.5 per share.

As the company plans to expand its network of IVF centres, how might this impact access to fertility treatments in India?